Robert Barrie

Gilead will donate vials of its antifungal medication AmBisome to help global efforts in eliminating visceral leishmaniasis.

The tender offer is for €51.29 per share, representing a 13% premium on Recordati's share price before the takeover was first disclosed.

Via the deals, Lilly is buying biotechs with lead programmes in preventing shingles, bacteria, and Epstein-Barr Virus.

The EMA's CHMP delivered two positive opinions, which will likely see an expansion of Novo Nordisk's Wegovy offerings in Europe.

The US biotech's technology integrates multiple protein modalities to simultaneously target a variety of disease mechanisms.

Roche has bought partial rights to Nurix Therapeutics' bexobrutideg in a deal worth up to $2.3bn that will see the big pharma company help advance

Nuvalent’s two late-stage lung cancer assets – zidesamtinib and neladalkib – are currently under FDA review

A spokesperson for the Chinese company said “we will take immediate action” following the military designation.

The Pentagon has judged that Wuxi AppTec qualifies as a Chinese military company, adding strain to already delicate ties between the pharmaceutical manufacturer and the US.

Parabilis’ US listing means the biotech IPO record has been broken twice in as many months as public listings continue hot streak.